Biodesix Inc (BDSX) support and resistance · rev $52.4M
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
This page maps Biodesix Inc (BDSX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BDSX revenue for 2026-06-30 was $52.4M. Net income was -$15.1M. BDSX currently screens at market cap $157.6M.
BDSX currently screens at market cap $157.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BDSX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BDSX quote page for the session range and the stock page for the full model.
Not investment advice.